Tuberkulose
-
Tuberkulose infektion og immunsuppression (2026)
Rekommandationer for udredning og behandling af tuberkulose infektion hos personer, som skal i immunsupprimerende behandling.
Version 2.0, 16.3.26. Udgivet af Dansk Selskab for Infektionsmedicin og Dansk Lungemedicinsk Selskab.
-
Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner.
Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Selskab (DDS) og Dansk Selskab for Infektionsmedicin (DSI).
-
Tuberkulose - diagnostik og behandling (2023)Denne vejledning omhandler diagnostik og behandling af voksne med TB, herunder pulmonal- og ekstrapulmonal-TB samt antibiotika-resistent TB.
For håndtering af infektioner forårsaget af andre mykobakterier henvises til anden litteratur.
26.09.23: Moxifloxacin varighed ændret til 8 uger (tabel 10)
-
SSI's overvågning af tuberkulose i Danmark
https://statistik.ssi.dk//sygdomsdata#!/?sygdomskode=TUBE&xaxis=Aar&show=Graph&datatype=Individual
-
Tuberkulose behandlingsskema
http://www.infmed.dk/download?UID=3ff1d1a0947bf5c199ad7f12d80e7c644f22d14e
-
Handbook on tuberculosis laboratory diagnostic methods in the European Union
-
SSI's opgørelse over tuberkulose 2019-20 i Danmark
-
Sundhedsstyrelsens vejledning om forebyggelse af tuberkulose (2015)
https://www.sst.dk/udgivelser/2015/vejledning-om-forebyggelse-af-tuberkulose
-
ECDC Tuberculosis surveillance and monitoring in Europe (2020)
-
WHO Tuberculosis surveillance and monitoring report in Europe
https://www.who.int/europe/publications/i/item/9789289061834
-
WHO Towards tuberculosis elimination (2014): an action framework for low-incidence countries
http://apps.who.int/iris/bitstream/handle/10665/132231/9789241507707_eng.pdf
-
Region Hovedstadens vejledning om diagnostik og behandling af tuberkulose
-
Region Hovedstadens vejledning om smitteopsporing
-
Pretreatment out-of-pocket costs for people with drug-resistant tuberculosis in Bandung, IndonesiaPLoS One Infectious DiseasesTilføjet 2. juli 2026
-
Correction: Bayesian hierarchical modeling of joint spatiotemporal risk patterns for Human Immunodeficiency Virus (HIV) and Tuberculosis (TB) in KenyaPLoS One Infectious DiseasesTilføjet 25. juni 2026
-
Spatiotemporal patterns of prevalence and mortality from respiratory infections and tuberculosis across Japan and its prefecturesPLoS One Infectious DiseasesTilføjet 18. juni 2026
-
Study on the safety evaluation of latent tuberculosis treatment in high‑risk groups for tuberculosis development: Study protocol for a multi‑center prospective observational cohort study in Korea (STEP-TB)PLoS One Infectious DiseasesTilføjet 10. juni 2026
-
Retraction: Determinants of correct knowledge on tuberculosis transmission and self-reported tuberculosis prevalence among general population aged 15–49 years in MyanmarPLoS One Infectious DiseasesTilføjet 30. maj 2026
-
Identification of risk areas and associated factors of unfavorable treatment outcomes in drug-resistant tuberculosis: Evidence from Rio de Janeiro, BrazilPLoS One Infectious DiseasesTilføjet 8. maj 2026
-
Tracking tuberculosis control using detailed population health and satellite luminosity data: findings from KazakhstanPLoS One Infectious DiseasesTilføjet 23. april 2026
-
Rifapentine Dosing for Drug-Susceptible Tuberculosis: Stage 1 of a Seamless Phase 2/3 Randomized Clinical TrialClinical Microbiology and InfectionTilføjet 12. april 2026
-
Geographical distribution of Mycobacterium tuberculosis complex lineages in sub-Saharan Africa: An interactive review.International Journal of Infectious DiseasesTilføjet 10. april 2026
-
Determinants of tuberculosis presentation and successful treatment outcome among tuberculosis patients in Geita, TanzaniaPLoS One Infectious DiseasesTilføjet 8. april 2026
-
Comments on” The risk of latent tuberculosis infection in patients with type 2 diabetes mellitus according to use of sodium-glucose cotransporter 2 inhibitors: A national database cohort study”International Journal of Infectious DiseasesTilføjet 4. april 2026
-
Spatiotemporal patterns and inter-provincial inequalities of pulmonary tuberculosis in China from 2000 to 2024, with projections to 2030International Journal of Infectious DiseasesTilføjet 3. april 2026
-
Factors Predicting successful treatment outcome with novel BPaLM/BPaL regimen in individuals with drug-resistant tuberculosis: Experience From IndonesiaPLoS One Infectious DiseasesTilføjet 2. april 2026
-
A periplasmic protein complex mediates arabinofuranosyltransferase activity and intrinsic drug resistance in Mycobacterium tuberculosisScience AdvancesTilføjet 2. april 2026
-
QT Interval Prolongation and Cardiotoxicity in Shorter Regimens for Rifampicin Resistant TuberculosisInternational Journal of Infectious DiseasesTilføjet 2. april 2026
-
Prevalence, perceptions and factors associated with non-adherence to hepatotoxicity monitoring among people living with HIV on tuberculosis preventive treatment at Mulago ISS clinicPLoS One Infectious DiseasesTilføjet 31. marts 2026
-
From T-cell sensitization to molecular–intelligent stratification: a roadmap for precision diagnosis of latent tuberculosis infectionClinical Microbiology ReviewsTilføjet 31. marts 2026
-
Prevalence and Mortality of Tuberculosis at HIV Diagnosis in Spain, 2004–2024International Journal of Infectious DiseasesTilføjet 27. marts 2026
-
Analysis of Accessibility to Anti-Tuberculosis Drugs in the Asia-Pacific Region between 2019 and 2022International Journal of Infectious DiseasesTilføjet 26. marts 2026
-
Emergence of Rv0678 (mmpR5) Mutations Mediating Resistance to Bedaquiline and Clofazimine in a Liver Transplant Recipient with Rifampicin-Susceptible Tuberculosis: A Case ReportInternational Journal of Infectious DiseasesTilføjet 26. marts 2026